VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate and international tax policy and research and development tax credits (no specific bills). Issues related to the Orphan Drug Tax Credit. Issues related to corporate and international tax policy in HR 5376, "Build Back Better Act," and related provisions debated in Senate (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KWAMME ANDERSON | — |
| SCOTT BARNES | — |
| MATTHEW O SCHUMAKER | — |
Health Issues HCR
Issues related to access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); Issues related to pharmaceutical pricing (HR 3, "Elijah E. Cummings Lower Drug Costs Now Act"; HR 19, "Lower Costs, More Cures Act"; S 2164, "Lower Costs, More Cures Act"); S Res 477, expressing support for the designation of September 2021 as "Sickle Cell Disease Awareness Month"; HR 6000, "Cures 2.0"; and, Issues related to health care and prescription drug pricing in HR 5376, "Build Back Better Act," and Senate companion legislation (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KWAMME ANDERSON | — |
| SCOTT BARNES | — |
| MATTHEW O SCHUMAKER | — |
Medicare/Medicaid MMM
Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KWAMME ANDERSON | — |
| SCOTT BARNES | — |
| MATTHEW O SCHUMAKER | — |
Budget/Appropriations BUD
Issues related to funding for the Food and Drug Administration (S 2599 and HR 4356: "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022.")
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BARNES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.